Detalles de la búsqueda
1.
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis.
Cochrane Database Syst Rev;
1: CD011381, 2024 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38174776
2.
Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis.
Cochrane Database Syst Rev;
11: CD012186, 2023 11 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38032059
3.
Educational interventions to improve detection and management of cognitive decline in primary care-An Italian multicenter pragmatic study.
Front Psychiatry;
13: 1050583, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36506451
4.
Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.
Cochrane Database Syst Rev;
5: CD013444, 2022 05 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35510826
5.
Brain Metabolism and Amyloid Load in Individuals With Subjective Cognitive Decline or Pre-Mild Cognitive Impairment.
Neurology;
2022 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35487700
6.
Identifying unanswered questions and setting the agenda for future systematic research in Multiple Sclerosis. A worldwide, multi-stakeholder Priority Setting project.
Mult Scler Relat Disord;
60: 103688, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35245817
7.
Reliability of the revised Cochrane risk-of-bias tool for randomised trials (RoB2) improved with the use of implementation instruction.
J Clin Epidemiol;
141: 99-105, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34537386
8.
Multiple Sclerosis International Federation guideline methodology for off-label treatments for multiple sclerosis.
Mult Scler J Exp Transl Clin;
7(4): 20552173211051855, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34900327
9.
Rituximab for people with multiple sclerosis.
Cochrane Database Syst Rev;
11: CD013874, 2021 11 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34748215
10.
[Engaging clinicians to identify and prioritize disinvestment opportunities in the treatment of neurodegenerative diseases: a qualitative study.] / Coinvolgere i clinici per identificare e dare priorità alle opportunità di disinvestimento nel trattamento delle malattie neurodegenerative: uno studio qualitativo.
Recenti Prog Med;
111(9): 503-514, 2020 09.
Artículo
en Italiano
| MEDLINE | ID: mdl-32914778
11.
The IN-DEEP project "INtegrating and Deriving Evidence, Experiences, Preferences": a web information model on magnetic resonance imaging for people with multiple sclerosis.
J Neurol;
267(8): 2421-2431, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32361839
12.
Clinical presentation of young people (10-24 years old) with brain tumors: results from the international MOBI-Kids study.
J Neurooncol;
147(2): 427-440, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32124185
13.
Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
Cochrane Database Syst Rev;
3: CD009628, 2020 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32119112
14.
Vitamin D for the management of multiple sclerosis.
Cochrane Database Syst Rev;
9: CD008422, 2018 09 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-30246874
15.
Tau Mutations Serve as a Novel Risk Factor for Cancer.
Cancer Res;
78(13): 3731-3739, 2018 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29794074
16.
Producing an evidence-based treatment information website in partnership with people affected by multiple sclerosis.
Health Sci Rep;
1(3): e24, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30623063
17.
Efficacy and Safety of Extracranial Vein Angioplasty in Multiple Sclerosis: A Randomized Clinical Trial.
JAMA Neurol;
75(1): 35-43, 2018 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29150995
18.
Ocrelizumab appears to reduce relapse and disability in multiple sclerosis but quality of evidence is moderate.
Evid Based Med;
22(6): 215-216, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29117998
19.
Zonisamide for essential tremor.
Cochrane Database Syst Rev;
8: CD009684, 2017 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-28836659
20.
Identifying Relapses in Multiple Sclerosis Patients through Administrative Data: A Validation Study in the Lazio Region, Italy.
Neuroepidemiology;
48(3-4): 171-178, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28793295